Method Development and Simultaneous Estimation of Amikacin Sulphate by Using UV and HPLC/ RP-HPLC

A common therapy for serious infections brought on by Gram-negative bacteria, including those that are resistant to many drugs, is amikacin sulphate, a semi-synthetic aminoglycoside antibiotic that is developed from kanamycin A¹. It inhibits protein synthesis and causes bacterial cell death by binding permanently to the 30S ribosomal subunit of bacteria. Amikacin is widely utilised in hospital settings because of its broad-spectrum action and therapeutic significance, especially in the treatment of potentially fatal diseases such septicaemia, respiratory tract infections, and urinary tract infections². In the pharmaceutical business, ensuring the efficacy, safety, and quality of amikacin sulphate in pharmaceutical formulations is crucial. In order to accurately identify, quantify, and monitor the medication in bulk and dose forms, analytical technique development is essential to this procedure. Validated analytical techniques are required for quality assurance and control by regulatory bodies as IP, USP, and ICH³.

Amikacin sulphate's absence of a strong chromophore makes direct detection using UV spectrophotometry challenging, which is one of the main issues with its analysis. Therefore, by creating UV-absorbing compounds, derivatization procedures are frequently used to improve its detectability. For this reason, common reagents like ninhydrin and o-phthalaldehyde are frequently utilised⁴. When compared to sophisticated chromatographic procedures, UV spectrophotometric approaches may be less sensitive and specific, despite being quick, easy, and economical⁵.

For the measurement of amikacin sulphate, reverse phase high performance liquid chromatography (RP-HPLC) has become a very popular and dependable analytical method. High sensitivity, specificity, accuracy, and the capacity to examine intricate pharmaceutical formulations are among the benefits of RP-HPLC⁶. It is especially helpful for stability investigations, impurity profiling, and simultaneous estimate of amikacin in conjunction with other medications⁷.

A number of factors, such as mobile phase composition, pH, flow rate, column type, and detection wavelength, must be carefully chosen and optimised during the development of analytical techniques. Additionally, method validation is necessary to guarantee the analytical process's dependability and repeatability. ICH criteria are followed for evaluating validation parameters such linearity, accuracy, precision, specificity, limit of detection (LOD), limit of quantification (LOQ), and robustness⁸.

The development of effective, economical, and ecologically friendly analytical techniques has gained attention in recent years. It is anticipated that combining cutting-edge methods with green chemistry strategies would enhance analytical performance while lessening the impact on the environment⁹.

The goal of this study is to give a thorough overview of the method development and simultaneous estimation of amikacin sulphate using RP-HPLC and UV spectrophotometry, emphasising important issues, validation needs, and their importance in pharmaceutical quality assurance¹⁰.

CHEMICAL PROFILE OF AMIKACIN SULPHATE:

Table.1: Chemical profile of Amikacin Sulphate^9-12

NEED FOR METHOD DEVELOPMENT:

1. Regulatory Compliance: To satisfy requirements imposed by the Indian Pharmacopoeia Commission, the United States Pharmacopoeia, and the International Council for Harmonisation, approved analytical procedures must be developed¹³.
2. Analytical Challenges of Amikacin: Because amikacin sulphate lacks a strong chromophore, direct UV detection is challenging and requires derivatization or sophisticated methods like RP-HPLC¹¹.
3. Precise Quantification in Formulations: Guarantees accurate drug content assessment when excipients and intricate pharmaceutical matrices are present.
4. Studies on stability and degradation are necessary to determine shelf life under various storage settings and to identify degradation products¹³.
5. Batch-to-batch uniformity, quality control testing, and the safety and effectiveness of pharmaceutical products are all supported by quality assurance and routine analysis¹².

UV SPECTROPHOTOMETRIC METHODS:

UV spectrophotometry is a simple and cost-effective technique used for the estimation of amikacin sulphate. However, due to the absence of a strong chromophore, direct UV detection is difficult.

To overcome this limitation, derivatization techniques such as ninhydrin and o-phthalaldehyde (OPA) are used to form UV-absorbing complexes, allowing detection typically around 330–340 nmu99i88yu99¹⁴.

Procedure

• Prepare standard solution
• Add derivatizing reagent
• Measure absorbance
• Plot calibration curve

Advantages

• Simple and rapid
• Economical

Limitations

• Low specificity
• Requires derivatization¹⁵

RP-HPLC METHOD DEVELOPMENT:

1. Select suitable C18 column based on drug properties.
2. Prepare and optimize mobile phase (buffer + organic solvent).
3. Adjust pH of buffer for better peak shape and resolution.
4. Set appropriate flow rate and injection volume.
5. Choose suitable detection wavelength (with derivatization if required).
6. Perform trial runs and optimize parameters to obtain a sharp, symmetric peak^16-17.

SIMULTANEOUS ESTIMATION APPROACH:

1. Simultaneous estimation is used to analyse amikacin with other drugs in combination formulations.
2. UV method uses multi-wavelength or derivative spectroscopy for separation.
3. RP-HPLC separates drugs based on different retention times.
4. Mobile phase is optimized to prevent overlapping of peaks.
5. Calibration curves are prepared individually for each drug.
6. It enables rapid, accurate, and cost-effective analysis in a single run^19-20.

METHOD VALIDATION (ICH Q2 (R1) GUIDELINES:

• Validation ensures reliability and accuracy of the analytical method as per International Council for Harmonisation.
• Linearity confirms proportional response between concentration and absorbance/peak area.
• Accuracy determines closeness of measured value to the true value (recovery studies).
• Precision evaluates repeatability and reproducibility of the method (%RSD).
• Specificity ensures no interference from excipients or impurities.
• LOD and LOQ define the lowest detectable and quantifiable concentrations^21-23.

COMPARATIVE ANALYSIS: UV vs. RP-HPLC:

• UV method is simple and economical, whereas RP-HPLC is advanced and costly.
• UV has low sensitivity, while RP-HPLC offers high sensitivity.
• UV shows low specificity, whereas RP-HPLC provides high specificity.
• UV is suitable for routine analysis, while RP-HPLC is ideal for complex formulations.
• UV requires derivatization, whereas RP-HPLC may reduce or better handle such limitations.
• RP-HPLC gives more accurate and reproducible results compared to UV method^24-25.

APPLICATIONS IN QUALITY ASSURANCE:

1. Used for routine analysis of amikacin in bulk and dosage forms.
2. Ensures batch-to-batch consistency during manufacturing.
3. Applied in stability studies to monitor degradation products.
4. Helps in detection of impurities and contaminants.
5. Supports regulatory compliance and documentation.
6. Used for validation and quality control testing in pharmaceutical industries.

CHALLENGES AND FUTURE PERSPECTIVES:

The lack of a potent chromophore in amikacin sulphate's chemical structure, which makes direct detection using UV spectrophotometry challenging, is one of the main issues with its study. Because of this restriction, derivatization methods such reaction with ninhydrin or o-phthalaldehyde must be used to improve its detectability. Derivatization, however, increases the analytical process's complexity, duration, and potential for experimental mistakes by adding additional phases.

Interference from excipients and degradation products found in pharmaceutical formulations is another major problem. These elements may have an impact on the analytical method's specificity and accuracy, especially when using UV spectrophotometric methods.

Furthermore, it can be challenging to achieve appropriate separation and peak resolution in RP-HPLC, necessitating careful optimisation of variables including flow rate, pH, and mobile phase composition.

Another difficulty in pharmaceutical analysis is the need for high sensitivity and precision, particularly when identifying traces of contaminants or degradation products. Furthermore, some laboratories may not be able to use sophisticated analytical tools like RP-HPLC due to their high cost and technical complexity.

Future studies should concentrate on creating analytical techniques for amikacin sulphate measurement that are more sensitive, selective, and quick. Superior sensitivity and specificity are provided by sophisticated methods like Liquid Chromatography–Mass Spectrometry (LC-MS/MS), which may be investigated for more precise analysis.

Green analytical techniques that minimise the use of dangerous solvents and lessen their impact on the environment are increasingly gaining popularity. The creation of analytical methods may be made more accurate, less prone to human mistake, and more efficient by using automation and artificial intelligence (AI).

Enhancing pharmaceutical quality assurance will also be greatly aided by the development of stability-indicating procedures and real-time analytical techniques. Future analytical techniques will be more dependable, effective, and sustainable thanks to these developments.

CONCLUSION

To guarantee the quality, safety, and therapeutic effectiveness of amikacin sulphate, analytical techniques for its estimation must be developed and validated. Conventional UV spectrophotometric techniques are best suited for routine and preliminary examination since they lack a strong chromophore and require derivatization to attain sufficient sensitivity. RP-HPLC techniques, on the other hand, provide better sensitivity, specificity, and repeatability, which makes them very useful for stability investigations, simultaneous estimation, and the study of complicated pharmaceutical formulations. Reliability and regulatory compliance in pharmaceutical quality assurance are ensured by using validated techniques in conformance with International Council for Harmonisation principles. According to a comparative analysis, RP-HPLC is the method of choice in sophisticated analytical labs because it yields more accurate and exact findings than UV techniques, which are more affordable and straight forward. It is anticipated that ongoing developments in analytical technologies, such as the adoption of green chemical methods and contemporary techniques like LC-MS, would improve method efficiency and sustainability despite current obstacles such derivatization needs and analytical complexity. All things considered, the use of reliable analytical techniques is essential to upholding pharmaceutical standards and promoting further drug analysis research and development.

REFERENCES

1. Maheshwari ML. A rapid HPLC–DAD method for quantification of amikacin in pharmaceuticals and biological samples. J Pharm Anal. 2020;10:123–130.
2. El-Dien FAN, et al. Development of a sensitive HPLC method for determination of amikacin. J Chromatogr A. 2023;1702:463–470.
3. Korany MAT, Haggag RS, Ragab MA, Elmallah OA. Liquid chromatographic determination of amikacin sulphate after derivatization. J Chromatogr Sci. 2014;52(8):837–847.
4. Li D, He S, Deng Y, et al. Development and validation of HPLC method for determination of amikacin. Bull Environ Contam Toxicol. 2014;93:47–52.
5. Sardella R, et al. Optimized extraction and RP-HPLC analysis of amikacin in biological samples. Molecules. 2021;26:665.
6. Kalyani L, Rao CVN. Stability-indicating RP-HPLC method for cefepime and amikacin. Braz J Pharm Sci. 2018;54:1–9.
7. Chauhan B, Jalalpure S. UHPLC method for analysis of amikacin in human serum. Pharm Methods. 2016;7:99–103.
8. Ovalles JF, Brunetto MR, Gallignani M. HPLC determination of amikacin using derivatization. J Pharm Anal. 2005;39:294–298.
9. Galanakis EG, Megoulas NC, Solich P, Koupparis MA. LC method for determination of amikacin. J Pharm Biomed Anal. 2006;40:1114–1120.
10. Nicoli S, Santi P. Assay of amikacin in biological samples by HPLC. J Pharm Biomed Anal. 2006;41:994–997.
11. Serrano JM, Silva M. Determination of amikacin using HPLC with chemiluminescence detection. J Chromatogr B. 2006;843:20–24.
12. Adams E, et al. Liquid chromatographic analysis of amikacin using electrochemical detection. J Chromatogr A. 1998;819:93–97.
13. Oguri S, Miki Y. Determination of amikacin by capillary electrophoresis. J Chromatogr B. 1996;686:205–210.
14. Feng CH, Lin S. HPLC analysis of amikacin in plasma. Chromatographia. 2001;53:213–217.
15. Zawilla NH, et al. Improved RP-HPLC method for analysis of amikacin. J Pharm Biomed Anal. 2007;43:168–173.
16. Zhu Y, Zhao H. Determination of aminoglycosides including amikacin by electrophoresis. J Chromatogr A. 2009;877:333–338.
17. Brajnoski G, et al. Determination of amikacin in cerebrospinal fluid by HPLC. J Chromatogr B. 2008;867:149–152.
18. Kim BH, Lee SC, Lee HJ. RP-HPLC method for aminoglycosides using derivatization. Biomed Chromatogr. 2003;17:396–403.
19. Dan H, Yang L. HPLC determination of amikacin using post-column derivatization. Chin J Anal Chem. 2009;29:1025–1028.
20. Vimal D. RP-HPLC method for simultaneous estimation of amikacin combinations. J Pharm Sci Bio Sci Res. 2012;2:138–143.
21. Chang MH, et al. Analytical methods for aminoglycoside antibiotics. Anal Chem. 2010;82:123–130.
22. Baietto L, et al. HPLC analysis of antibiotics including amikacin. J Chromatogr B. 2010;878:123–130.
23. Baranowska I, et al. Determination of aminoglycosides by chromatographic techniques. J Chromatogr A. 2006;1129:36–45.
24. Oertel R, et al. HPLC analysis of aminoglycosides in biological samples. J Chromatogr B. 2004;807:129–135.
25. Caturla MC, Cusido E. Determination of amikacin by chromatographic methods. J Chromatogr A. 1992;593:113–120.
26. Wong LT, et al. Determination of amikacin by HPLC after derivatization. J Chromatogr B. 1982;231:145–154.
27. Confino M, Panayot T. Analytical derivatization methods for aminoglycosides. Anal Chim Acta. 1990;235:123–130.
28. Gupta VD, et al. Hantzsch reaction-based derivatization for drug analysis. J Pharm Sci. 1984;73:112–115.
29. Chang SY, et al. Analytical challenges in aminoglycoside determination. Anal Bioanal Chem. 2010;397:456–462.
30. Stead S. Review of analytical techniques for aminoglycoside antibiotics. J Chromatogr A. 2000;882:1–13.